Unity Biotechnology, Inc. Deferred Tax Assets, Net of Valuation Allowance
Unity Biotechnology, Inc. had Deferred Tax Assets, Net of Valuation Allowance of $0 as of 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2025-03-07
- 2024-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2023-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2022-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2021-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-07 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-07 |
| 2022-12-31 | $0.00 10-K · filed 2024-04-15 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-15 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-15 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-23 |
| 2017-12-31 | $69.00K 10-K · filed 2019-03-06 |